Autism News and Research

Latest Autism News and Research

Hyperbaric oxygen therapy treatment ineffective for children with autism

Research conducted by the Center for Autism and Related Disorders, Inc. (CARD), shines new light on the effects of a popular form of hyperbaric oxygen therapy (HBOT) treatment for children with autism and related disorders. The "Randomized Trial of Hyperbaric Oxygen Therapy for Children with Autism" study reveals that HBOT, consisting of 24% oxygen delivered at 1.3 atmospheres of pressure, does not have a significant effect on symptoms of autism.

10 Nov 2009

Autism Spectrum Therapies approved to deliver ABA services to TRICARE military insurance beneficiaries

Autism Spectrum Therapies, an agency providing behavior therapy and other autism services in Southern California, has been approved to provide behavioral services for TRICARE military insurance beneficiaries. This designation makes AST eligible to deliver Applied Behavior Analysis (ABA) services to individuals with autism in military families in the San Diego area.

10 Nov 2009

Children with ASD have problem with handwriting: Study

Handwriting skills are crucial for success in school, communication, and building children's self-esteem. The first study to examine handwriting quality in children with autism spectrum disorders (ASD) has uncovered a relationship between fine motor control and poor quality of handwriting in children with ASD, according to research published in the November 10, 2009, issue of Neurology-, the medical journal of the American Academy of Neurology.

10 Nov 2009

Children and young people with autism should be offered special teaching support

Teachers and parents must be vigilant in observing difficulties with language comprehension, reading and spelling in children and young people with autism, Asperger's syndrome and ADHD.

10 Nov 2009

Washington insurance program may be a national model, Massachusetts may expand autism services

News outlets report on health issues at the state level including a health insurance program in Washington State and a bill to increase coverage for autism services in Massachusetts.

10 Nov 2009

Children with autism may have lower quality handwriting, says study

Children with autism may have lower quality handwriting and trouble forming letters compared to children without autism, according to a study published in the November 10, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology.

9 Nov 2009

Autism Consortium holds its fourth annual symposium to update on autism

The Autism Consortium, an innovative collaboration of researchers, clinicians, funders and families dedicated to catalyzing research and enhancing clinical care for autism spectrum disorders (ASDs), held its fourth annual symposium on October 28th, 2009, at Harvard Medical School in Boston.

6 Nov 2009

$1.85 million grant to study how digital games can improve players' health behaviors and outcomes

The Robert Wood Johnson Foundation (RWJF) today announced more than $1.85 million in grants for research that will offer unprecedented insight into how digital games can improve players' health behaviors and outcomes. With funding from RWJF's Health Games Research national program, nine research teams across the country will conduct extensive studies to discover, for example, how the popular dance pad video game Dance Dance Revolution might help Parkinson's patients reduce the risk of falling, how Wii Active might be most effectively implemented in high schools to help overweight students lose weight, how a mobile phone game with a breath interface might help smokers quit or reduce their tobacco use, or how facial recognition games might be designed to help people with autism learn to identify others' emotions.

From Evident Corporation - Life Sciences 6 Nov 2009

Study finds oral dimercaptosuccinic acid effective in treating children with autism

Two studies published by the Southwest College of Naturopathic Medicine in the October issue of BMC Clinical Pharmacology investigated the use of oral dimercaptosuccinic acid (DMSA), a prescription medicine approved by the FDA for treating lead poisoning, and used off-label in these studies for treating heavy metal toxicity in children with autism.

5 Nov 2009

Marianjoy Rehabilitation Hospital offers behavioral testing for children

Marianjoy Rehabilitation Hospital now provides neuropsychological assessments and testing for children ages 5 to 18 who are exhibiting behavioral issues or academic difficulties.

4 Nov 2009

International Omega-3 Awareness Day to educate public about proven health benefits of omega-3

Scientific evidence of the health benefits of omega-3's are now so firmly established that omega-3 expert Carol A. Locke, MD, with a team of world-renowned doctors, has spearheaded the first ever International Omega-3 Awareness Day on March 3rd, 2010. Learn more at www.Omega3Day.com.

4 Nov 2009

Maximum Potential's video-based ABA therapy program approved

Maximum Potential Group today announces that their video-based ABA (Applied Behavior Analysis) therapy program has now been endorsed by renowned autism expert Dr. James W. Partington, Ph.D., BCBA-D. Dr. Partington is the director of Behavior Analysts, Inc., and creator of the ABLLS(R)-R and the WebABLLS(R).

4 Nov 2009

Researchers identify part of the brain that responds to both facial and vocal expressions of emotion

Researchers at the University of York have identified a part of the brain that responds to both facial and vocal expressions of emotion.

3 Nov 2009

Seaside Therapeutics commences STX107 Phase 1 clinical trial for Fragile X Syndrome

Seaside Therapeutics LLC today announced that the Company has initiated a Phase 1 clinical trial of STX107, a highly potent, selective mGluR5 antagonist, in development for the treatment of Fragile X Syndrome. The single ascending dose study is designed to evaluate the safety, tolerability and pharmacokinetics of STX107 in healthy volunteers. Fragile X Syndrome is the most common inherited form of mental impairment and the most common known cause of autism.

3 Nov 2009

Phase 1 study of STX107 for Fragile X syndrome begins

NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile X syndrome, the most common inherited cause of intellectual disability. There has to date been no medication that could alter the disorder's neurologic abnormalities. The study will evaluate safety, tolerability, and optimal dosage in healthy volunteers.

3 Nov 2009

AST develops two new holiday season tip sheets for families of children with autism

Autism Spectrum Therapies (AST), an agency providing behavior therapy and other autism services throughout Southern California, has developed two new holiday season tip sheets especially for families of children with autism: Stress-Free Holidays and Top Toy Recommendations.

3 Nov 2009

WCMC-Q's biomedical research program makes significant progress

The biomedical research program of Weill Cornell Medical College in Qatar has made significant progress in its dual goals of advancing basic science and building a sustainable research community in Qatar since it was launched less than a year and a half ago.

2 Nov 2009

Meeting to understand gastrointestinal problems in children with ASDs to be held

Autism Speaks, the American Academy of Pediatrics (AAP) and the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) will host one of the largest gatherings of researchers, clinicians and pediatric specialists to better understand the gastrointestinal (GI) problems in children with autism spectrum disorders (ASDs).

31 Oct 2009

Exposure to mercury-based preservative in vaccines is minimal, says researchers

The injectable, multi-dose H1N1 vaccine contains the mercury-based preservative thimerosol to reduce risks of bacterial contamination. The presence of thimerosol has once again raised concerns whether there are risks posed to children when the tiny amount of mercury contained in thimerosol is included in a vaccine.

31 Oct 2009

NARSAD to present Productive Lives Award to Randy Lewis

Randy Lewis, the SVP of supply chain and logistics for Walgreens, the nation’s largest drugstore chain, will receive the first ever Productive Lives Award from NARSAD tonight at its 22nd annual New York Awards Dinner at the Pierre Hotel.

30 Oct 2009

Autism News and Research

Latest Autism News and Research

Hyperbaric oxygen therapy treatment ineffective for children with autism

Autism Spectrum Therapies approved to deliver ABA services to TRICARE military insurance beneficiaries

Children with ASD have problem with handwriting: Study

Children and young people with autism should be offered special teaching support

Washington insurance program may be a national model, Massachusetts may expand autism services

Children with autism may have lower quality handwriting, says study

Autism Consortium holds its fourth annual symposium to update on autism

$1.85 million grant to study how digital games can improve players' health behaviors and outcomes

Study finds oral dimercaptosuccinic acid effective in treating children with autism

Marianjoy Rehabilitation Hospital offers behavioral testing for children

International Omega-3 Awareness Day to educate public about proven health benefits of omega-3

Maximum Potential's video-based ABA therapy program approved

Researchers identify part of the brain that responds to both facial and vocal expressions of emotion

Seaside Therapeutics commences STX107 Phase 1 clinical trial for Fragile X Syndrome

Phase 1 study of STX107 for Fragile X syndrome begins

AST develops two new holiday season tip sheets for families of children with autism

WCMC-Q's biomedical research program makes significant progress

Meeting to understand gastrointestinal problems in children with ASDs to be held

Exposure to mercury-based preservative in vaccines is minimal, says researchers

NARSAD to present Productive Lives Award to Randy Lewis

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Autism News and Research

Latest Autism News and Research

Pharmaceutical Manufacturing - Industry Focus eBook eBook

Evolving spectrophotometry for modern biopharma workflows

Scaling B-cell cloning workflows for antibody development

Fluidics in Modern Healthcare & Medical Device Innovation

Newsletters you may be interested in